CRISPR THERAPEUTICS AG
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $271.3M
Liabilities Breakdown FY2017
Total Liabilities: $83.5M
Asset Breakdown
Total Assets: $271.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $239.8M | 88.4% |
| Accounts Receivable | $2.6M | 1.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $18.9M | 6.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $344.0K | 0.1% |
| Other Assets | $9.8M | 3.6% |
Liabilities Breakdown
Total Liabilities: $83.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.6M | 2.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $81.9M | 98.0% |